KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other Accumulated Expenses (2016 - 2026)

Biogen has reported Other Accumulated Expenses over the past 18 years, most recently at $2.5 billion for Q1 2026.

  • For Q1 2026, Other Accumulated Expenses rose 0.64% year-over-year to $2.5 billion; the TTM value through Mar 2026 reached $2.5 billion, up 0.64%, while the annual FY2025 figure was $2.8 billion, 0.18% changed from the prior year.
  • Other Accumulated Expenses for Q1 2026 was $2.5 billion at Biogen, down from $2.8 billion in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $3.8 billion in Q3 2023 and troughed at $2.2 billion in Q1 2022.
  • A 5-year average of $2.7 billion and a median of $2.6 billion in 2023 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: grew 29.61% in 2022 and later decreased 28.22% in 2024.
  • Year by year, Other Accumulated Expenses stood at $2.5 billion in 2022, then rose by 4.05% to $2.6 billion in 2023, then increased by 7.02% to $2.8 billion in 2024, then decreased by 0.18% to $2.8 billion in 2025, then decreased by 9.13% to $2.5 billion in 2026.
  • Business Quant data shows Other Accumulated Expenses for BIIB at $2.5 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.8 billion in Q3 2025.